Luminescence Technology Corp. (TPEX:6729)

Intra-Cellular Therapies Revenue

In the year 2024, Luminescence Technology had annual revenue of 112.94M TWD with 12.60% growth. Luminescence Technology had revenue of 61.80M in the half year ending December 31, 2024, with 19.17% growth.

• Revenue: 112.94M
• Revenue Growth: +12.60%
• P/S Ratio: 5.75
• Revenue / Employee: 2.75M
• Employees: 41
• Market Cap: 649.16M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	112.94M	12.64M	12.60%
Dec 31, 2023	100.30M	-7.64M	-7.07%
Dec 31, 2022	107.94M	3.97M	3.82%
Dec 31, 2021	103.97M	19.79M	23.51%
Dec 31, 2020	84.18M	-2.54M	-2.92%